All In MedTech

Device Trial Radar · NCT02615379

Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion

A Prospective, Randomized, Parallel Pilot Study of Transdermal, Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion

Last checked: Nov 20, 2026Latest source record: Aug 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Jul 1, 2017

Primary completion

Dec 31, 2017

Study completion Mar 31, 2019

Sponsor

Lead sponsor
Neogenix, LLC dba OgenixNot on our public-company list
Sponsor type
Industry
First posted
Nov 26, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

EPIFLO® unit along with standard wound care vs only standard wound care for Surgical site infections (SSI).

Conditions

  • Instrumented Spinal Fusion

Interventions

  • EPIFLODevice

    Transdermal continuous oxygen therapy is oxygen delivery to the wound site directly. Ogenix makes a small portable oxygen concentrator (Trade Name: EPIFLO) that makes continuous transdermal delivery of oxygen possible. It is a 3 ounce oxygen generator that continuously delivers 3 ml of pure oxygen to the wound site.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of surgical site infectionTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Neurological Surgery Allegheny General Hospital

    Pittsburgh, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.